Basalt Thread

About

Steady Lantern 53 is an independent resource on ibogaine’s cultural history, scientific record, safety concerns, and evolving regulation. Our work focuses on careful context, separating preliminary signals, lived experience, and established evidence.

Close photographic detail used as an editorial feature image.

Our editorial approach

We curate material with an evidence-first mindset: primary registries, peer-reviewed literature, regulatory documents, and lived accounts are each treated with clear labels about their evidentiary weight. To illustrate how we separate sources in practice, you will find contextual links woven into explanatory prose throughout our pages; for services-oriented visitors we also outline offerings on our services page and link back to the site index from subpages to keep navigation straightforward.

We prioritize publicly verifiable sources: registry reports, clinical trial records, government health advisories and university publications. For example, we reference authoritative context such as the FDA's public pages or university summaries when describing regulatory timelines; reliable background on pharmacology is regularly cross-checked with entries like the relevant Wikipedia overview and institutional resources to avoid misstatements (Ibogaine — Wikipedia).

Contributors document each claim with a traceable source and a note on interpretation. When describing regulatory or safety information we consult primary government guidance (for example, clinical trial registration and advisory pages available through recognized public health sites) and academic literature hosted by universities for context (National Institutes of Health).

What we cover

We organize content into compact modules: explanatory articles, timeline panels, annotated source lists, and a research landscape that separates early reports from confirmed evidence. The site uses progressive disclosure—tabs and expandable cards—so readers can browse summaries or reveal full citations without overwhelming scrolling. Our editorial architecture mirrors this approach on related subpages; for readers exploring practitioner or treatment-centered material we include contextual links to service-focused pages such as ibogainetherapyforptsd.com when those resources are directly relevant to an explanatory paragraph.

Summaries

Short, evidence-graded briefs that highlight provenance and uncertainty.

Timeline panels

Compact chronological modules that let readers expand decades of material.

Research landscape

An annotated index of trials, registries, and peer-reviewed syntheses.

Editorial principles

Our work is guided by concise, practical standards designed to keep readers informed and safe.

  • Evidence before claims — We label the strength of assertions and prioritize primary, peer-reviewed, or regulatory sources.
  • Safety context — Whenever content touches on risks we include clear advisory language and source citations.
  • Cultural respect — We acknowledge traditional contexts and separate reporting on cultural practice from clinical claims.
  • Plain language — Content is written to be accessible without sacrificing precision.
  • Independence — Financial or institutional conflicts are disclosed; editorial control remains internal.

To support these principles we consult authoritative external guidance on evidence synthesis and public-health reporting; readers can verify methodological norms through reputable institutions such as the National Institutes of Health and methodological overviews like the Evidence-based medicine summary for background on evidence grading.

Independent by design

Basalt Thread is an independent information resource and not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice. For service-oriented pages where readers may seek care options, we link sparingly and with clear context to external sites such as ibogainestock.com, ibogainebwiti.com, and ibogaineboxers.com when they are directly relevant to an explanatory sentence.

If you arrived from clinical or help-seeking pages, note we also overview potential benefits and harms in context on companion pages including summaries hosted at ibogainebenefits.com. For quick navigation back to the site's entry points, use the index link above or the site navigation; our front page overview collects feature modules and timeline entry points.